Clinical Trial Update: Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma

View source ↗

Summary

This completed clinical trial evaluated whole-brain tumor burden metrics along with inflammatory and molecular markers to predict postoperative neurocognitive d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioma
• Oligodendroglioma

Snippet

Sponsor: West China Hospital | Conditions: Glioma, Glioma : Oligodendroglioma or Astrocytoma | Status: COMPLETED